https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-03 / J Control Release 2022 Sep;349:844-875
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-03 / J Control Release 2022 Sep;349:844-8752022-08-03 00:00:002022-08-03 00:00:00Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-01 / Int Immunopharmacol 2022 Sep;110:1090162022-08-01 00:00:002022-08-01 00:00:00Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-25 / Epigenomics 2022 Jul;14(14):865-886
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-25 / Epigenomics 2022 Jul;14(14):865-8862022-07-25 00:00:002022-07-25 00:00:00Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-22 / Front Mol Biosci 2022;9:816510
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-22 / Front Mol Biosci 2022;9:8165102022-07-22 00:00:002023-03-07 13:25:25Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-3065
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-30652022-07-15 00:00:002022-07-15 00:00:00An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-313
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-3132022-07-14 00:00:002022-07-14 00:00:00Personalized tumor vaccine for pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-09 / Heliyon 2022 Jul;8(7):e09915
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-09 / Heliyon 2022 Jul;8(7):e099152022-07-09 00:00:002022-07-09 00:00:00Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-615
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-6152022-07-07 00:00:002022-07-07 00:00:00Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-04 / Front Mol Biosci 2022;9:889403
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-04 / Front Mol Biosci 2022;9:8894032022-07-04 00:00:002022-07-04 00:00:00Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-06-17 / Pharm Res 2022 Aug;39(8):1851-1866
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-06-17 / Pharm Res 2022 Aug;39(8):1851-18662022-06-17 00:00:002022-06-17 00:00:00Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
